news
Azithromycin and doxycycline of no benefit to COVID-19 patients, finds analysis
Trial finds neither azithromycin nor doxycycline meaningfully improve recovery times or reduce risk of hospitalisation in non-hospitalised COVID-19 patients.
List view / Grid view
azithromycin
news
Phase IIb trial to study hydroxychloroquine and azithromycin as COVID-19 treatment launched
A double-blind clinical trial has begun in the US to study hydroxychloroquine and azithromycin treatment in patients with COVID-19.
news
EMA warns about side effects of chloroquine and hydroxychloroquine for COVID-19 treatment
The COVID-19 European Medicines Agency (EMA) pandemic Task Force (COVID-ETF) warned that chloroquine and hydroxychloroquine are yet to be proved effective at treating COVID-19 and that their side effects could be fatal.
news
UK national priority COVID-19 trial now recruiting patients
The PRINCIPLE trial aims to evaluate therapeutics that could slow the progression of COVID-19 symptoms in patients most at risk of complications.
news
Zoliflodacin shows promise in treating uncomplicated gonorrhea
Zoliflodacin was found to be effective in curing all rectal gonorrheal infections in patients during a Phase II clinical trial...
news
How did gonorrhoea become a drug-resistant superbug?
Scientists show how the gonorrhoea bacterium resists last-resort antibiotic ceftriaxone while maintaining a robust growth rate...
news
Low-cost drugs package saves lives of people starting HIV treatment late
Treating people who start HIV treatment late with a package of low-cost drugs to prevent serious infections saves three lives for ...
